Canonic Information

View Top Employees from Canonic

Canonic is a subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), developing medical Cannabis products through a Computational Predictive Biology (CPB) platform. The company’s products in development are aimed at improving active compounds yield, genetic stability and Cannabis varieties for specific medical indications. The company’s strategy includes the development of Cannabis varieties in order to commercialize medical Cannabis products independently or through collaborations. Canonic has exclusive access to Evogene’s genomic assets and technology for the development of medical Cannabis products. For more information, please visit: https://www.canonicbio.com/

Website	http://canonicbio.com
Employees	7 (0 on RocketReach)
Founded	2019
Technologies	JavaScript , HTML , PHP +15 more (view full list)
Industry	Biotechnology Research, Health Care, Medical
Keywords	Plant Biotechnology, Medical Cannabis, Active Compounds, Cannabis Products, Computational Biology, Pharmaceutical Cannabis, Cannabis Research, Plant Genomics, Biotechnology, Drug Discovery, Genetic Engineering, Plant Breeding, Biopharma, Therapeutics, Cannabis Science, Natural Medicine, Clinical Trials, Precision Medicine, Synthetic Biology
Competitors	Novozymes, Twist Bioscience, Synthego Corporation, Geno, Zymergen, Inc., Synlogic, Evogene, Sestina Bio, LLC. +42 more (view full list)